Recently published data generated by researchers at The University of Queensland and Vaxxas shows effective delivery of a nucleic acid-based COVID-19 vaccine in a preclinical animal study ...

The DNA vaccine, owned by private biotechnology ... publication of data supporting the effective use of its high-density microarray patch (HD-MAP) technology to deliver nucleic acid-based vaccines ...

LuxScan 10K Microarray Scanner is a compact high performance system for microarray imaging and data analysis of DNA, protein and cell arrays. Its advanced systems for optics, signal processing and ...

Jangan diabaikan, Parents perlu paham tentang Dandy Walker Syndrome, kelainan bawaan yang memengaruhi perkembangan otak.

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

The American College of Medical Genetics and Genomics (ACMG) welcomed six new directors, including a new president-elect, to its Board of Directors at the 2025 ACMG Annual Clinical Genetics Meeting in ...

Measurement of DNA, RNA and protein concentration (UV and colorimetric) Incorporation rate of fluorescent molecules (550 nm/650 nm), e. g., for microarray experiments Enzymatic assays (e.g ...

A microarray is a set of samples, for example DNA, RNA or proteins, arranged on a solid substrate or chip, such as a glass slide or silicon film, that is used in high throughput experiments.

A team has used a process known as DNA origami to make electrochemical sensors that can quickly detect and measure biomarkers. Using an approach called DNA origami, scientists at Caltech have ...

Government and private funding for genomic research is the key factor driving market revenue growth. According to the Alzheimer’s Disease International, As of June 2024, it is anticipated that more ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8517 ...

Officinae Bio's AI-driven sequence optimization expands Maravai's family of brands, enabling rapid, cost-effective nucleic acid therapy development Venice, Italy-based Officinae Bio's proprietary ...